22:22 IST
BSE
Other Announcement
Novelix Pharmaceuticals Other Announcement
Novelix Pharmaceuticals informs shareholders that the Annual Report for FY 2025-26 and the 32nd AGM notice are available on the Company's website.
Novelix Pharmaceuticals Ltd
- Share price
- ₹70.38
- Market cap
- ₹124.0 Cr
- Revenue (annual)
- ₹132.3 Cr
- Net profit (annual)
- ₹2.56 Cr
- P/E (TTM)
- 34.2×Sector 67.6×
- Promoter holding
- 54.29%+4.86% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
22:16 IST
BSE
Annual Report
Novelix Pharmaceuticals Annual Report
Novelix Pharmaceuticals filed its Annual Report and AGM Notice for the financial year 2025-26. The 32nd Annual General Meeting is scheduled for September 30, 2026.
18:13 IST
BSE
Financial Results
Novelix Pharmaceuticals Q1 FY27 Results: Net Profit ₹1.2 Cr, Up 1100.0% YoY
Novelix Pharmaceuticals Ltd reported revenue from operations of ₹36.9 Cr (+64.7% YoY) and net profit of ₹1.2 Cr (+1100.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.2 Cr · +1100.0% YoY